Comparison of a new medical device with domperidone in functional dyspepsia: a randomized, cross-over, controlled study.]

Marcello Covino, Massimo Montalto, Giovanni Battista Gasbarrini, Antonella Gallo, Maria Giovinale, Claudia Fonnesu

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

AIM: Management of functional dyspepsia is still controversial. Different controlled trials reported a superiority of prokinetics, H2-receptor antagonists and proton-pump inhibitors over placebo; nevertheless, symptomatic improvement after therapy is often incomplete and some of these drugs possess serious side effects. The aim of the study was to evaluate the efficacy of a new medical device in respect to domperidone in patients with functional dyspepsia. METHODS: In a cross-over, randomized trial, 36 patients with functional dyspepsia ingested two daily doses of a medical device (Digerfast) or domperidone (Peridon) for 21 days. Clinical evaluation was performed at baseline (T0) and after 21 days (T1) for each treatment. A Visual Analogue Scale (VAS) and the generic scale 36-item Short Form (SF-36) were used to assess symptom intensity and changes in health-related quality of life, respectively. RESULTS: At T0 no statistical difference was found for each symptom between medical device and domperidone. At T1 both treatments significantly improved in respect to baseline values all the evaluated gastrointestinal symptoms (P<0.5 for all comparisons) except for vomiting. No difference in gastrointestinal symptoms between the two treatments was found at T1. Regarding SF-36 evaluation, at T0 no statistical differences were found for each SF-36 parameter between the two regimens. At T1 both treatments significantly improved most of the evaluated SF-36 parameters in respect to baseline values. No difference in SF-36 parameters between the two treatments was found at T1. CONCLUSION: Both the medical device and domperidone significantly improved gastrointestinal symptoms and quality of life in subjects with functional dyspepsia, not showing significant difference in efficacy.
Titolo tradotto del contributo[Autom. eng. transl.] Comparison of a new medical device with domperidone in functional dyspepsia: a randomized, cross-over, controlled study.]
Lingua originaleItalian
pagine (da-a)133-139
Numero di pagine7
RivistaMinerva Medica
Volume2011
Stato di pubblicazionePubblicato - 2011

Keywords

  • domperidone
  • dyspepsia

Fingerprint

Entra nei temi di ricerca di 'Comparison of a new medical device with domperidone in functional dyspepsia: a randomized, cross-over, controlled study.]'. Insieme formano una fingerprint unica.

Cita questo